Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
αv Integrins mediate adhesion and migration of breast carcinoma cell lines
Authors
Nanette C. Wong
Barbara M. Mueller
Carlos F. Barbas
Pete Ruminski
Vito Quaranta
Emme C. K. Lin
Jeffrey W. Smith
Publication date
01-01-1998
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/1998
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006512018609

Other articles of this Issue 1/1998

Clinical & Experimental Metastasis 1/1998 Go to the issue

OriginalPaper

Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns

OriginalPaper

Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

OriginalPaper

Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration

OriginalPaper

Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro

OriginalPaper

Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin

OriginalPaper

Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits